Contact
Please use this form to send email to PR contact of this press release:
Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration
TO:
Please use this form to send email to PR contact of this press release:
Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration
TO: